Matthew Stober

Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ.

PIramed Ltd. develops drugs, diagnostics, and other therapeutic products. It develops treatment for cancers which include proliferation, invasion, angiogenesis, and metastasis. The company was co-founded by Michael Waterfield, Peter Parker, and Paul Workman in 2003 and is headquartered in Slough, UK.

Oxford Immunotec Ltd. operates as a medical diagnostic company. It develops and sells medical diagnostic products. The company was founded by Peter Wrighton-Smith in 2002 and is headquartered in Abingdon, the United Kingdom.

LongueVue Capital LLC (LongueVue Capital) is a private equity firm founded in 2001 by Rick S. Rees and John C. McNamara. The firm is headquartered in New Orleans, Louisiana.

Altimmune UK Ltd. engages in the discovery and development of prophylactic and therapeutic vaccines against mutating viruses and cancer. It provides T-cell vaccines to protect patients against infectious diseases (most notably mutating viruses) and to treat cancers; and Flunisyn, a DepoVaccine to protect against influenza. The company was founded by Bertrand Georges in 2003 and is headquartered in London, the United Kingdom.

PolyTherics Ltd. develops biomedical polymers for therapeutic applications. The company was founded by Antony Godwin, Sunil Shaunak and Steve Brocchini in 2001 and is headquartered in Babraham, the United Kingdom.

Sancilio & Co., Inc. operates as specialty pharmaceutical company. It develops and markets based products including those based on the proprietary Advanced Lipid Technologies platform. The company was founded by Frederick D. Sancilio in 2005 and is headquartered in Riviera Beach, FL.

Part of Patheon, Inc., Patheon Pharmaceuticals, Inc. is a trusted end-to-end contract development and manufacturing organization partner for the pharmaceutical, biotech, and life sciences industries. The private company is based in Durham, NC. Benefit from a single vendor along your entire development journey by relying on their clinical trial services’ support network and expertise.

Abzena (Cambridge) Ltd. provides antibody engineering and immunogenicity screening services. The company was founded in 2004 and is headquartered in Babraham, the United Kingdom.

Banner Life Sciences LLC operates as clinical-stage pharmaceutical company. The company is headquartered in High Point, NC.

Locus Biosciences, Inc. develops CRISPR-engineered precision antibacterial products for antibiotic-resistant bacterial infections and microbiome-related disease. The firm offers CRISPR-engineered bacteriophage and CRISPR-Cas3 phage. The company was founded by Charles Gersbach, Dave Ousterout, Chase Beisel, Paul M. Garofolo, Nick Taylor, and Rodolphe Barrangou in 2015 and is headquartered in Morrisville, NC.

Kiniciti is a platform company that invests in and partners with companies to strengthen the cell and gene therapy ecosystem. The company, which is based in New York, NY, was founded by Geoffrey Michael Glass, who has been the CEO since incorporation. Kiniciti is backed by private equity firm Welsh, Carson, Anderson & Stowe (WCAS) and Biospring Partners. The company offers a highly tailored, collaborative, and flexible investment and strategic support model to ensure the promise of cell and gene therapeutics is delivered quickly and safely to patients worldwide. The leadership team includes professionals experienced in investing in and building successful companies across the life sciences sector.

Astro Bidco Ltd. is a British biopharmaceutical company founded in 2018 that specializes in integrated drug discovery, design, optimization, manufacturing, and chemistry services.